Boston Scientific
BSX
543 hedge funds and large institutions have $29.5B invested in Boston Scientific in 2016 Q2 according to their latest regulatory filings, with 82 funds opening new positions, 193 increasing their positions, 184 reducing their positions, and 23 closing their positions.
257% more first-time investments, than exits
New positions opened: 82 | Existing positions closed: 23
67% more call options, than puts
Call options by funds: $68.1M | Put options by funds: $40.7M
44% more funds holding in top 10
Funds holding in top 10: 16 → 23 (+7)
25% more capital invested
Capital invested by funds: $23.7B → $29.5B (+$5.88B)
11% more funds holding
Funds holding: 491 → 543 (+52)
5% more repeat investments, than reductions
Existing positions increased: 193 | Existing positions reduced: 184
1.09% less ownership
Funds ownership: 94.24% → 93.16% (-1.1%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
+$534M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$299M |
| 3 |
BG
Bollard Group
Boston,
Massachusetts
|
+$167M |
| 4 |
Millennium Management
New York
|
+$139M |
| 5 |
VOYA Investment Management
Atlanta,
Georgia
|
+$133M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Diamond Hill Capital Management
Columbus,
Ohio
|
-$335M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$334M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
-$272M |
| 4 |
Winslow Capital Management
Minneapolis,
Minnesota
|
-$236M |
| 5 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
-$221M |
BSX Hedge Fund Activity: Q2 2016 in Review
543 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Boston Scientific (BSX) for Q2 2016, worth a combined $29.5B — up 25% from $23.7B a quarter earlier.
Buyers outnumbered sellers: 82 funds opened new BSX positions and 23 closed out — a net gain of 59 holders — while 193 added to existing stakes and 184 trimmed.
The largest buyer was JP Morgan Chase, adding an estimated $534M. The largest seller was Diamond Hill Capital Management, cutting an estimated $335M.
- 543 institutional investors held Boston Scientific (BSX) as of Q2 2016, up from 491 in Q1 2016.
- Funds reported $29.5B of Boston Scientific stock for Q2 2016, up 25% quarter-over-quarter.
- 82 funds opened new Boston Scientific positions in Q2 2016 and 23 closed out, a net change of +59 holders.
- The largest Boston Scientific buyer in Q2 2016 was JP Morgan Chase, an estimated $534M added.
- The largest Boston Scientific seller in Q2 2016 was Diamond Hill Capital Management, an estimated $335M sold.
Based on aggregated 13F filings for Q2 2016.